Macroplastique治疗女性固有括约肌缺陷所致压力性尿失禁的长期结局
回顾性分析2011年4月至2016年12月106例固有括约肌缺陷所致压力性尿失禁女性,接受Macroplastique注射后中位随访7.4年,总体成功率43%,54%一次注射成功,46%需≥2次注射,生活质量和沮丧感改善,17%失败者行二次自体吊带术。
要点
- 总体成功率43%,一次注射成功者占54%,需≥2次注射者占46%。
- 中位随访7.4年,中位注射量5 mL,中位年龄67岁。
- 失败组中17%选择二次自体吊带手术。
核心结论
- Macroplastique在部分固有括约肌缺陷所致压力性尿失禁女性中显示出长期良好结局。
研究设计与样本
- 经IRB批准,从前瞻性维护数据库中回顾性审查非神经源性固有括约肌缺陷所致压力性尿失禁接受Macroplastique注射的女性病历,排除随访<5年者,共106例,中位年龄67岁。
主要发现
- 中位随访7.4年,中位注射量5 mL,总体成功率43%。
- 成功者中54%在一次注射后成功,46%需要≥2次注射。
- 所有组别患者生活质量评分和IIQ-7第7题(沮丧感)均有改善。
- 失败组中17%选择二次自体吊带手术。
关键数值与推荐
- 固有括约肌缺陷定义为压力试验阳性且尿道支撑良好,并在有数据时Valsalva漏尿点压力低。
- 成功定义为末次Macroplastique注射后末次随访时UDI-6第3题评分为0-1分且无需额外抗尿失禁治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term outcomes of polydimethylsiloxane (Macroplastique (MPQ)) in women with stress urinary incontinence (SUI) secondary to intrinsic sphincter deficiency (ISD) using validated questionnaires. METHODS: Following IRB approval, charts of non-neurogenic women with SUI secondary to ISD who underwent MPQ injection were reviewed from a prospectively maintained database. ISD was defined as positive stress test with a well-supported urethra and low Valsalva leak point pressure when available. Excluded were women with follow-up <5years. Baseline data included validated questionnaire scores (UDI-6 question 3 (0-3), VAS Quality of Life, Incontinence Impact Questionnaire (IIQ-7)) and urodynamic study findings. Patients were followed with same questionnaires and three-dimensional ultrasound evaluating volume/configuration of MPQ. All three-dimensional ultrasound measurements were performed by the same imaging team blinded to clinical outcomes. Outcomes were evaluated in four groups based on prior SUI treatment. Success was defined as UDI-6 question 3 score of 0-1 and not requiring additional anti-incontinence therapy at the last visit after the last MPQ injection. RESULTS: From April 2011-December 2016, 106 patients (median age 67) met study criteria. Median follow-up time was 7.4years. Median MPQ injected was 5 mL. Overall success was 43%, with 54% successful after one injection and 46% requiring ≥2 injections. Across all groups, patients had improvement in Quality of Life and IIQ-7 Question 7 (frustration). Among the failure group, 17% opted for a secondary autologous sling procedure. CONCLUSION: MPQ demonstrated long-term favorable outcomes in a subset of women with SUI secondary to ISD.
引用
- Kusin SB, Carroll TF, Alhalabi F, et al. Long-term Outcomes With Macroplastique in Women With Stress Urinary Incontinence Secondary to Intrinsic Sphincter Deficiency. Urology. 2024. PMID: 38199277. doi:10.1016/j.urology.2023.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。